End results in central precocious puberty with GnRH analog treatment: The data of the Italian Study Group for Physiopathology of Puberty

F. Antoniazzi, T. Arrigo, M. Cisternino, F. Galluzzi, S. Bertelloni, A. M. Pasquino, P. Borrelli, D. Osio, F. Mengarda, F. De Luca, L. Tato

Research output: Contribution to journalArticle

Abstract

We report some end results with GnRH agonist (GnRHa) treatment in central precocious puberty (CPP), in terms of final height (FH), ovarian function, peak bone mass, body composition and psychological problems. The two studies reported (Study I and II) are part of the activity of the Italian Study Group for Physiopathology of Puberty. Study I. Growth data were analyzed of three groups of patients: treated with i.n. spray buserelin, i.m. triptorelin and untreated. Both GnRHa administration modes were effective in arresting pubertal development and all girls had complete recovery of the reproductive axis after therapy. Treated patients showed an improvement in final height in comparison with untreated patients and compared to predicted height at the start of treatment with both agonist treatments. However, patients treated with the long-acting slow release preparation had a better improvement in adult height and reached or exceeded the genetic height potential. Study II. In a retrospective evaluation of the outcome in 71 girls with idiopathic CPP treated with triptorelin, we found that FH fell within the population norm and the target range in 87.3% and 90% of the patients respectively. The tallest FH was recorded in the patients who started therapy at less than 6 years of age and in those who discontinued treatment at a bone age of 12.0-12.5 yr. Finally, we and other groups have recently found normal values of bone mineral density in girls at the end of GnRHa treatment in the great majority of patients.

Original languageEnglish
Pages (from-to)773-780
Number of pages8
JournalJournal of Pediatric Endocrinology and Metabolism
Volume13
Issue numberSUPPL. 1
Publication statusPublished - 2000

Keywords

  • Bone mineral density
  • Central precocious puberty
  • Final height
  • GnRH agonists

ASJC Scopus subject areas

  • Endocrinology
  • Pediatrics, Perinatology, and Child Health

Fingerprint Dive into the research topics of 'End results in central precocious puberty with GnRH analog treatment: The data of the Italian Study Group for Physiopathology of Puberty'. Together they form a unique fingerprint.

  • Cite this

    Antoniazzi, F., Arrigo, T., Cisternino, M., Galluzzi, F., Bertelloni, S., Pasquino, A. M., Borrelli, P., Osio, D., Mengarda, F., De Luca, F., & Tato, L. (2000). End results in central precocious puberty with GnRH analog treatment: The data of the Italian Study Group for Physiopathology of Puberty. Journal of Pediatric Endocrinology and Metabolism, 13(SUPPL. 1), 773-780.